Clinical Trials Browser

Observational × Alpelisib × 90 days × Clear all

NCT06083038 2026-05-06

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

Breast Neoplasms, Hyperglycemia